Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-469-3 | CAS number: 60-32-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 May 2017 - 28 July 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Qualifier:
- according to guideline
- Guideline:
- other: KeratinoSens™, EURL ECVAM DB-ALM Protocol No. 155, July 1st, 2015
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- activation of keratinocytes
Test material
- Reference substance name:
- Aminocaproic acid
- EC Number:
- 200-469-3
- EC Name:
- Aminocaproic acid
- Cas Number:
- 60-32-2
- Molecular formula:
- C6H13NO2
- IUPAC Name:
- 6-aminohexanoic acid
- Test material form:
- solid
Constituent 1
In vitro test system
- Details on the study design:
- Skin sensitisation (In vitro test system)
Cell line used: KeratinoSensTM (Givaudan, Switzerland)
Technical material and conditions:
- Maintenance Medium: D-MEM with 1.0 g/L D-glucose and Na-Pyruvate + 10 % FBS + 1 % Geneticin (final concentration: 500 µg/mL)
- Assay Medium: D-MEM with 1.0 g/L D-glucose and Na-Pyruvate + 10 % FBS
- Test Item Exposure Medium: D-MEM with 1.0 g/L D-glucose and Na-Pyruvate + 1 % FBS
- Luciferace reagent: Luciferase Assay Substrate (Promega, Cat. No.: E1501)
- Assay Buffer: Luciferase Assay Buffer (Promega, Cat. No.: E1501)
- Lysisbuffer: Luciferase Cell Culture Lysis (Promega Cat. No.: E1531)
- MTT Solution: MTT stock solution: 5 mg/mL MTT in DPBS
- SDS solution: 10% (wlv) SDS in dist. water
- DPBS solution: DPBS solution (without Ca2+/Mg2+)
Controls used:
- Vehicle control: DMSO: 1% (vlv) in test item exposure medium
- Positive control: Cinnamic aldehyde in DMSO, 4 µM, 8 µM, 16 µM; 32 µM; 64 µM
- Blank control: vehicle control without cells
Test procedure:
Each concentration step of the test item (twelve concentrations) and the positive control was assessed in three replicates in every independent run. The negative control was assessed using six replicates per plate in every independent run. The test substance was incubated with a luciferase reporter cell line (LuSens cells) for ca. 48 h at 37 °C and antioxidant response element (ARE) dependent luciferase activity was measured in a plate reader. Cell viability was determined by a MTT assay. The test substance was incubated for 4 h at 37 °C ± 1 °C and 5% CO2. Afterwards the medium was removed and replaced by 10% SDS solution the plate was incubated at 37 °C ± 1 °C and 5% CO2 overnight. The OD was measured at A = 600 nm.
Data Analysis:
For each test item two independent repetitions using separately prepared test item solutions and independently harvested cells are necessary to derive a prediction. Each independent run consists of three replicates for every concentration step of the test item and the positive control. In case of discordant results a third independent run should be performed.
Acceptance criteria:
- The luciferase activity induction of the positive control is statistically significant above the threshold of 1.5 (using a t-test) in at least one of the tested concentrations.
- The average induction in the three technical replicates for the positive control at a concentration of 64 µM is between 2 and 8.
- The EC1.5 value of the positive control is within two standard deviations of the historical mean.
- The average coefficient of variation (CV; consisting of 6 wells) of the luminescence reading for the negative (solvent) control DMSO is <20% in each repetition.
Evaluation of results:
The test item is considered positive if the following conditions were met in at least two independently prepared test repetitions:
- Imax is >1.5 fold increased and statistically significant (p <0.05) compared to the negative control
- cell viability is >70% at the lowest concentration with an induction of luciferase activity >1.5
- EC1.5 value is <1000 µM
- an apparent overall dose-response for luciferase induction
If in a given repetition, all of the three first conditions are met but a clear dose-response for the luciferase induction cannot be observed, the result of that repetition is considered as inconclusive and further testing may be required. In addition, a negative result obtained with concentrations <1000 µM is considered as inconclusive.
Results and discussion
- Positive control results:
- The luciferase activity induced by the positive control at a concentration of 64 µM was between 2 and 8 (3.26 (experiment 1); 6.31 (experiment 2); 5.70 (experiment 3)). Therefore, the positive control fullfilled the validity criteria of the test.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: Imax
- Value:
- 1.24
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: EC1.5 [µM]
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- not determinable
- Key result
- Run / experiment:
- other: 2
- Parameter:
- other: Imax
- Value:
- 1.02
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: 2
- Parameter:
- other: EC1.5 [µM]
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- not determinable
- Key result
- Run / experiment:
- other: 3
- Parameter:
- other: Imax
- Value:
- 1.15
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Parameter:
- other: EC1.5 [µM]
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- not determinable
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
- Acceptance criteria met for variability between replicate measurements: yes
Any other information on results incl. tables
Table1: Results of the Cytotoxicity Measurement
|
Concentration [µM] |
Cell Viability [%] |
||||
Experiment 1 |
Experiment 2 |
Experiment 3 |
Mean |
SD |
||
Solvent Control |
- |
100.0 |
100.0 |
100.0 |
100.0 |
0.0 |
Positive Control |
4.00 |
92.5 |
94.3 |
102.4 |
96.4 |
5.2 |
8.00 |
99.0 |
102.2 |
105.5 |
102.2 |
3.2 |
|
16.00 |
93.9 |
102.4 |
112.2 |
102.8 |
9.2 |
|
32.00 |
91.4 |
105.8 |
106.2 |
101.1 |
8.4 |
|
64.00 |
85.0 |
106.7 |
121.1 |
104.3 |
18.2 |
|
Test Item |
0.98 |
87.6 |
104.4 |
110.4 |
100.8 |
11.9 |
1.95 |
129.2 |
98.3 |
103.6 |
110.3 |
16.5 |
|
3.91 |
122.4 |
101.9 |
96.6 |
107.0 |
13.6 |
|
7.81 |
114.1 |
93.4 |
99.1 |
102.2 |
10.7 |
|
15.63 |
100.3 |
94.6 |
98.5 |
97.8 |
2.9 |
|
31.25 |
87.0 |
86.4 |
94.7 |
89.4 |
4.7 |
|
62.50 |
57.6 |
92.0 |
101.5 |
83.7 |
23.1 |
|
125.00 |
28.2 |
100.4 |
95.2 |
74.6 |
40.3 |
|
250.00 |
52.5 |
97.7 |
92.8 |
81.0 |
24.8 |
|
500.00 |
42.3 |
108.3 |
95.1 |
81.9 |
34.9 |
|
1000.00 |
35.1 |
102.7 |
94.7 |
77.5 |
36.9 |
|
2000.00 |
31.0 |
102.8 |
108.2 |
80.7 |
43.1 |
Table2: Induction of Luciferase Activity Experiment 1
Experiment 1 |
Concentration [µM] |
Fold Induction |
Significance |
||||
Rep. 1 |
Rep. 2 |
Rep. 3 |
Mean |
SD |
|||
Solvent Control |
- |
1.00 |
1.00 |
1.00 |
1.00 |
0.00 |
|
Positive Control |
4.00 |
1.07 |
1.21 |
1.03 |
1.10 |
0.10 |
|
8.00 |
1.20 |
1.31 |
1.50 |
1.34 |
0.15 |
|
|
16.00 |
1.31 |
1.34 |
1.39 |
1.35 |
0.04 |
|
|
32.00 |
1.43 |
1.98 |
2.32 |
1.91 |
0.45 |
* |
|
64.00 |
2.71 |
4.17 |
2.90 |
3.26 |
0.79 |
* |
|
Test Item |
0.98 |
0.70 |
1.39 |
0.97 |
1.02 |
0.35 |
|
1.95 |
1.11 |
1.07 |
0.95 |
1.04 |
0.09 |
|
|
3.91 |
0.85 |
1.19 |
0.85 |
0.96 |
0.20 |
|
|
7.81 |
0.99 |
1.08 |
0.84 |
0.97 |
0.12 |
|
|
15.63 |
1.25 |
1.32 |
1.15 |
1.24 |
0.08 |
|
|
31.25 |
1.57 |
1.01 |
0.87 |
1.15 |
0.37 |
|
|
62.50 |
0.97 |
0.90 |
0.78 |
0.88 |
0.10 |
|
|
125.00 |
1.07 |
1.03 |
1.03 |
1.04 |
0.02 |
|
|
250.00 |
1.01 |
0.92 |
0.76 |
0.90 |
0.13 |
|
|
500.00 |
0.84 |
1.18 |
1.10 |
1.04 |
0.18 |
|
|
1000.00 |
0.87 |
0.96 |
0.91 |
0.91 |
0.05 |
|
|
2000.00 |
0.75 |
1.11 |
1.15 |
1.00 |
0.22 |
|
* = significant induction according to Student’s t-test, p<0.05
Table3: Induction of Luciferase Activity Experiment 2
Experiment 2 |
Concentration [µM] |
Fold Induction |
Significance |
||||
Rep. 1 |
Rep. 2 |
Rep. 3 |
Mean |
SD |
|||
Solvent Control |
- |
1.00 |
1.00 |
1.00 |
1.00 |
0.00 |
|
Positive Control |
4.00 |
1.19 |
1.24 |
1.06 |
1.16 |
0.09 |
|
8.00 |
1.16 |
1.12 |
1.32 |
1.20 |
0.11 |
|
|
16.00 |
1.37 |
1.55 |
1.59 |
1.50 |
0.12 |
* |
|
32.00 |
2.02 |
2.27 |
2.16 |
2.15 |
0.13 |
* |
|
64.00 |
6.51 |
5.74 |
6.68 |
6.31 |
0.50 |
* |
|
Test Item |
0.98 |
0.83 |
1.11 |
1.13 |
1.02 |
0.16 |
|
1.95 |
0.81 |
0.92 |
0.82 |
0.85 |
0.06 |
|
|
3.91 |
0.80 |
0.86 |
0.99 |
0.88 |
0.10 |
|
|
7.81 |
1.05 |
0.79 |
0.89 |
0.91 |
0.13 |
|
|
15.63 |
0.87 |
0.77 |
0.86 |
0.84 |
0.05 |
|
|
31.25 |
0.97 |
1.05 |
1.05 |
1.02 |
0.05 |
|
|
62.50 |
0.90 |
0.80 |
0.97 |
0.89 |
0.09 |
|
|
125.00 |
0.93 |
0.87 |
0.87 |
0.89 |
0.03 |
|
|
250.00 |
0.85 |
0.77 |
0.89 |
0.83 |
0.06 |
|
|
500.00 |
0.79 |
0.89 |
0.92 |
0.87 |
0.07 |
|
|
1000.00 |
0.87 |
0.88 |
0.57 |
0.77 |
0.17 |
|
|
2000.00 |
1.03 |
0.86 |
0.84 |
0.91 |
0.11 |
|
* = significant induction according to Student’s t-test, p<0.05
Table 4: Induction of Luciferase Activity Experiment 3
Experiment 3 |
Concentration [µM] |
Fold Induction |
Significance |
||||
Rep. 1 |
Rep. 2 |
Rep. 3 |
Mean |
SD |
|||
Solvent Control |
- |
1.00 |
1.00 |
1.00 |
1.00 |
0.00 |
|
Positive Control |
4.00 |
1.17 |
1.33 |
1.21 |
1.24 |
0.08 |
|
8.00 |
1.35 |
1.34 |
1.08 |
1.25 |
0.15 |
|
|
16.00 |
1.46 |
1.55 |
1.27 |
1.43 |
0.14 |
|
|
32.00 |
2.11 |
1.98 |
1.64 |
1.91 |
0.24 |
* |
|
64.00 |
6.96 |
5.89 |
4.26 |
5.70 |
1.36 |
* |
|
Test Item |
0.98 |
1.28 |
1.10 |
0.91 |
1.09 |
0.19 |
|
1.95 |
1.18 |
1.14 |
0.96 |
1.09 |
0.12 |
|
|
3.91 |
1.12 |
1.20 |
0.92 |
1.08 |
0.14 |
|
|
7.81 |
1.11 |
1.32 |
0.95 |
1.13 |
0.19 |
|
|
15.63 |
1.10 |
1.17 |
0.95 |
1.07 |
0.12 |
|
|
31.25 |
1.12 |
1.21 |
0.99 |
1.11 |
0.11 |
|
|
62.50 |
1.11 |
1.29 |
0.92 |
1.11 |
0.19 |
|
|
125.00 |
1.12 |
1.24 |
0.98 |
1.12 |
0.13 |
|
|
250.00 |
1.12 |
1.29 |
0.93 |
1.11 |
0.18 |
|
|
500.00 |
1.13 |
1.26 |
0.97 |
1.12 |
0.15 |
|
|
1000.00 |
1.08 |
1.26 |
0.93 |
1.09 |
0.16 |
|
|
2000.00 |
1.23 |
1.26 |
0.96 |
1.15 |
0.16 |
|
* = significant induction according to Student’s t-test, p<0.05
Table 5: Induction of Luciferase Activity – Overall Induction
|
Concentration [µM] |
Fold Induction |
Significance |
||||
Experiment 1 |
Experiment 2 |
Experiment 3 |
Mean |
SD |
|||
Solvent Control |
- |
1.00 |
1.00 |
1.00 |
1.00 |
0.00 |
|
Positive Control |
4.00 |
1.10 |
1.16 |
1.24 |
1.17 |
0.07 |
|
8.00 |
1.34 |
1.20 |
1.25 |
1.26 |
0.07 |
|
|
16.00 |
1.35 |
1.50 |
1.43 |
1.43 |
0.08 |
|
|
32.00 |
1.91 |
2.15 |
1.91 |
1.99 |
0.14 |
* |
|
64.00 |
3.26 |
6.31 |
5.70 |
5.09 |
1.62 |
* |
|
Test Item |
0.98 |
1.02 |
1.02 |
1.09 |
1.05 |
0.04 |
|
1.95 |
1.04 |
0.85 |
1.09 |
1.00 |
0.13 |
|
|
3.91 |
0.96 |
0.88 |
1.08 |
0.98 |
0.10 |
|
|
7.81 |
0.97 |
0.91 |
1.13 |
1.00 |
0.11 |
|
|
15.63 |
1.24 |
0.84 |
1.07 |
1.05 |
0.20 |
|
|
31.25 |
1.15 |
1.02 |
1.11 |
1.09 |
0.07 |
|
|
62.50 |
0.88 |
0.89 |
1.11 |
0.96 |
0.13 |
|
|
125.00 |
1.04 |
0.89 |
1.12 |
1.02 |
0.11 |
|
|
250.00 |
0.90 |
0.83 |
1.11 |
0.95 |
0.14 |
|
|
500.00 |
1.04 |
0.87 |
1.12 |
1.01 |
0.13 |
|
|
1000.00 |
0.91 |
0.77 |
1.09 |
0.93 |
0.16 |
|
|
2000.00 |
1.00 |
0.91 |
1.15 |
1.02 |
0.12 |
|
Table 6: Additional Parameters
Parameter |
Experiment 1 |
Experiment 2 |
Experiment 3 |
Mean |
SD |
EC1.5[µM] |
n.a. |
n.a. |
n.a. |
- |
- |
Imax |
1.24 |
1.02 |
1.15 |
1.14 |
0.11 |
IC30[µM] |
49.29 |
n.a. |
n.a. |
49.29 |
- |
IC50[µM] |
279.80 |
n.a. |
n.a. |
279.80 |
- |
EC1.5: interpolated concentration for a 1.5 fold luciferase induction, Imax: maximal induction factor of luciferase activity compared to the solvent (negative) control measured at any test chemical concentration, IC30: concentration effecting a reduction of cellular viability by 30%, IC50: concentration effecting a reduction of cellular viability by 50%, n.a. = not applicable
Table 7: Acceptance Criteria
Criterion |
Range |
Exp. 1 |
pass/fail |
Exp. 2 |
pass/fail |
Exp. 3 |
pass/fail |
CV Solvent Control |
< 20% |
17.8 |
pass |
8.4 |
pass |
9.9 |
pass |
No. of positive control concentration steps with significant luciferase activity induction >1.5 |
≥ 1 |
2.0 |
pass |
3.0 |
pass |
2.0 |
pass |
EC1.5 PC |
7 < x < 34 µM |
20.35 |
pass |
15.90 |
pass |
18.43 |
pass |
Induction PC at 64 µM |
2.00 < x < 8.00 |
3.26 |
pass |
6.31 |
pass |
5.70 |
pass |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study under the given conditions the test item did not induce the luciferase activity in the transgenic KeratinoSens™ cell line in at least two independent experiment runs. Therefore, the test item can be considered as non sensitiser. The data generated with this method may not be sufficient to conclude on the absence of skin sensitisation potential of chemicals and should be considered in the context of integrated approach such as IATA.
- Executive summary:
In the present study the test item was dissolved in dist. water. Based on a molecular weight of 131.17 g/mol a stock solution of 200 mM was prepared. Based on the stock solution a set of twelve master solutions in 100% solvent was prepared by serial dilution using a constant dilution factor of 1:2. These master solutions were diluted 1:100 in cell culture medium. The following concentration range was tested in the assay:
2000, 1000, 500, 250, 125, 62.5, 31.25, 15.63, 7.81, 3.91, 1.95, 0.98 µM. Cells were incubated with the test item for 48 h at 37°C. After exposure cells were lysed andluciferase activity was assessed by luminescence measurement.
In the first experiment, no significant luciferase induction >1.5 was found in the tested concentration range. Therefore, no EC1.5value could be calculated. Within this first experiment a cytotoxic effect could be observed starting from 62.50 µM onwards. In the second experiment,no significant luciferase induction >1.5 was found in the tested concentration range. Therefore, no EC1.5value could be calculated. Furthermore, no cytotoxic effect was observed within the second experiment. In the third experiment, no significant luciferase induction >1.5 was found in the tested concentration range. Therefore, no EC1.5value could be calculated. Furthermore, no cytotoxic effect was observed within the third experiment. No dose response for luciferase activity induction was observed for each individual run as well as for an overall luciferase activity induction. Under the condition of this study the test item is therefore considered as non sensitiser. The controls confirmed the validity of the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.